vs

Side-by-side financial comparison of BEYOND MEAT, INC. (BYND) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.

Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $61.6M, roughly 1.0× BEYOND MEAT, INC.). On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -19.7%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-49.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -9.7%).

Beyond Meat, Inc., branded as Beyond, is a producer of plant-based meat alternatives founded in 2009 by Ethan Brown. The company's products were first launched in the United States in 2012.

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

BYND vs CTKB — Head-to-Head

Bigger by revenue
CTKB
CTKB
1.0× larger
CTKB
$62.1M
$61.6M
BYND
Growing faster (revenue YoY)
CTKB
CTKB
+27.8% gap
CTKB
8.1%
-19.7%
BYND
More free cash flow
CTKB
CTKB
$48.0M more FCF
CTKB
$-1.8M
$-49.8M
BYND
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
-9.7%
BYND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BYND
BYND
CTKB
CTKB
Revenue
$61.6M
$62.1M
Net Profit
$-44.1M
Gross Margin
-11.5%
52.9%
Operating Margin
-211.4%
-9.0%
Net Margin
-70.9%
Revenue YoY
-19.7%
8.1%
Net Profit YoY
-557.1%
EPS (diluted)
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BYND
BYND
CTKB
CTKB
Q4 25
$61.6M
$62.1M
Q3 25
$70.2M
$52.3M
Q2 25
$75.0M
$45.6M
Q1 25
$68.7M
$41.5M
Q4 24
$76.7M
$57.5M
Q3 24
$81.0M
$51.5M
Q2 24
$93.2M
$46.6M
Q1 24
$75.6M
$44.9M
Net Profit
BYND
BYND
CTKB
CTKB
Q4 25
$-44.1M
Q3 25
$-110.7M
$-5.5M
Q2 25
$-29.2M
$-5.6M
Q1 25
$-52.9M
$-11.4M
Q4 24
$9.6M
Q3 24
$-26.6M
$941.0K
Q2 24
$-34.5M
$-10.4M
Q1 24
$-54.4M
$-6.2M
Gross Margin
BYND
BYND
CTKB
CTKB
Q4 25
-11.5%
52.9%
Q3 25
10.3%
52.7%
Q2 25
11.5%
52.3%
Q1 25
-1.5%
48.6%
Q4 24
13.1%
58.5%
Q3 24
17.7%
56.3%
Q2 24
14.7%
54.6%
Q1 24
4.9%
51.3%
Operating Margin
BYND
BYND
CTKB
CTKB
Q4 25
-211.4%
-9.0%
Q3 25
-160.0%
-17.6%
Q2 25
-46.6%
-23.3%
Q1 25
-81.8%
-36.1%
Q4 24
-49.3%
5.2%
Q3 24
-38.2%
-8.2%
Q2 24
-36.4%
-18.3%
Q1 24
-70.7%
-23.9%
Net Margin
BYND
BYND
CTKB
CTKB
Q4 25
-70.9%
Q3 25
-157.6%
-10.5%
Q2 25
-39.0%
-12.2%
Q1 25
-77.0%
-27.5%
Q4 24
16.8%
Q3 24
-32.8%
1.8%
Q2 24
-37.0%
-22.4%
Q1 24
-71.9%
-13.8%
EPS (diluted)
BYND
BYND
CTKB
CTKB
Q4 25
$0.68
Q3 25
$-1.44
Q2 25
$-0.38
Q1 25
$-0.69
Q4 24
$-0.65
Q3 24
$-0.41
Q2 24
$-0.53
Q1 24
$-0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BYND
BYND
CTKB
CTKB
Cash + ST InvestmentsLiquidity on hand
$203.9M
$90.9M
Total DebtLower is stronger
$415.7M
Stockholders' EquityBook value
$-997.0K
$341.7M
Total Assets
$614.7M
$461.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BYND
BYND
CTKB
CTKB
Q4 25
$203.9M
$90.9M
Q3 25
$117.3M
$93.3M
Q2 25
$103.5M
$75.5M
Q1 25
$102.1M
$95.3M
Q4 24
$131.9M
$98.7M
Q3 24
$121.7M
$162.3M
Q2 24
$144.9M
$177.9M
Q1 24
$157.9M
$168.8M
Total Debt
BYND
BYND
CTKB
CTKB
Q4 25
$415.7M
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Q1 24
$1.1B
Stockholders' Equity
BYND
BYND
CTKB
CTKB
Q4 25
$-997.0K
$341.7M
Q3 25
$-784.1M
$378.6M
Q2 25
$-677.0M
$377.6M
Q1 25
$-649.5M
$379.6M
Q4 24
$-601.2M
$395.7M
Q3 24
$-611.9M
$385.5M
Q2 24
$-590.0M
$389.1M
Q1 24
$-561.4M
$392.6M
Total Assets
BYND
BYND
CTKB
CTKB
Q4 25
$614.7M
$461.5M
Q3 25
$599.7M
$494.9M
Q2 25
$691.7M
$493.3M
Q1 25
$643.8M
$482.6M
Q4 24
$678.1M
$499.5M
Q3 24
$692.9M
$491.2M
Q2 24
$711.2M
$483.7M
Q1 24
$735.0M
$492.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BYND
BYND
CTKB
CTKB
Operating Cash FlowLast quarter
$-46.8M
$-771.0K
Free Cash FlowOCF − Capex
$-49.8M
$-1.8M
FCF MarginFCF / Revenue
-80.8%
-2.9%
Capex IntensityCapex / Revenue
4.8%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-157.2M
$-8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BYND
BYND
CTKB
CTKB
Q4 25
$-46.8M
$-771.0K
Q3 25
$-38.8M
$-3.9M
Q2 25
$-33.2M
$108.0K
Q1 25
$-26.1M
$-125.0K
Q4 24
$-29.0M
$2.0M
Q3 24
$-22.0M
$13.2M
Q2 24
$-16.0M
$6.2M
Q1 24
$-31.8M
$4.0M
Free Cash Flow
BYND
BYND
CTKB
CTKB
Q4 25
$-49.8M
$-1.8M
Q3 25
$-41.7M
$-4.6M
Q2 25
$-35.1M
$-1.5M
Q1 25
$-30.6M
$-974.0K
Q4 24
$-35.4M
$1.1M
Q3 24
$-24.1M
$12.2M
Q2 24
$-17.3M
$5.2M
Q1 24
$-33.0M
$3.4M
FCF Margin
BYND
BYND
CTKB
CTKB
Q4 25
-80.8%
-2.9%
Q3 25
-59.4%
-8.7%
Q2 25
-46.9%
-3.2%
Q1 25
-44.6%
-2.3%
Q4 24
-46.2%
1.9%
Q3 24
-29.7%
23.7%
Q2 24
-18.6%
11.0%
Q1 24
-43.7%
7.6%
Capex Intensity
BYND
BYND
CTKB
CTKB
Q4 25
4.8%
1.6%
Q3 25
4.1%
1.3%
Q2 25
2.6%
3.5%
Q1 25
6.5%
2.0%
Q4 24
8.4%
1.6%
Q3 24
2.5%
2.0%
Q2 24
1.4%
2.3%
Q1 24
1.6%
1.3%
Cash Conversion
BYND
BYND
CTKB
CTKB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.21×
Q3 24
14.05×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BYND
BYND

Segment breakdown not available.

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

Related Comparisons